21344-24-1 Usage
General Description
5-bromothieno[2,3-b]pyridine is a chemical compound with the molecular formula C9H6BrNS. It is a heterocyclic compound that contains both a thiophene and a pyridine ring, with a bromine atom attached to the thiophene ring. 5-bromothieno[2,3-b]pyridine is commonly used in research and pharmaceutical development, particularly in the synthesis of biologically active molecules. It may also be used as an intermediate in the production of agrochemicals and pharmaceuticals. 5-bromothieno[2,3-b]pyridine has potential applications in the field of organic and medicinal chemistry, and its unique structural features make it a valuable building block for the synthesis of new chemical entities with potential therapeutic properties. Its diverse range of applications and potential biological activity make it a valuable compound in chemical and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 21344-24-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,3,4 and 4 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 21344-24:
(7*2)+(6*1)+(5*3)+(4*4)+(3*4)+(2*2)+(1*4)=71
71 % 10 = 1
So 21344-24-1 is a valid CAS Registry Number.
21344-24-1Relevant articles and documents
SUBSTITUTED BENZOTHIOPHENYL DERIVATIVES AS GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES
-
Paragraph 0760, (2017/11/01)
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (I) as follows: wherein U1, U2, U3, R1, R2, Z, and W are defined herein.
PYRAZOLO [1, 5-A] PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS
-
Page/Page column 284, (2010/11/03)
The present invention provides methods for inhibiting mTOR using pyrazolo[1,5-a]pyrimidine compounds and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with mTOR using such compounds.